AKR1B1 and AKR1B10 as Potential Prognostic Biomarkers of Endometrial Cancer
Maja Novak Pušić, Špela Smrkolj, Tea Lanišnik Rižner · 2026
Read AKR1B1 and AKR1B10 as Potential Prognostic Biomarkers of Endometrial Cancer by Maja Novak Pušić, Špela Smrkolj, Tea Lanišnik Rižner (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13566823.txt.
Description
Maja Novak Pusic, Spela Smrkolj, and Tea Lanisnik Rizner test two blood proteins as outlook markers in womb cancer, in work from twenty twenty-six. Womb cancer is the most common cancer of the female organs, and cases keep rising. Doctors lack reliable blood tests to sort risk before surgery. The pilot study draws blood before surgery from older women with proven cancer. Lab assays measure two related proteins in the plasma.
One protein runs higher in the most aggressive grade of tumours. A model that blends both proteins with clinical traits sorts poorly, though. It cannot yet predict spread to vessel walls before surgery. Patients with both proteins below the middle level fare much better. They live longer and stay free of return for longer spans. The authors stress that the sample is small and results are early. Larger forward studies must confirm the signal.
Catalog record
| CREATOR | Maja Novak Pušić, Špela Smrkolj, Tea Lanišnik Rižner |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 32 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |